Serbia

Is Hemp Legal in Serbia?

Status

Legal

Covers

Hemp (General)

Jurisdiction

Independent Country

Last updated

May 29, 2026

The short answer

Industrial hemp is legal in Serbia when cultivated from EU-certified seed varieties with THC content at or below 0.3%. The Ministry of Agriculture, Forestry and Water Management, through the Plant Protection Administration, licenses growers, conducts plot inspections, and approves seed varieties.

Farmers must obtain prior cultivation permits, register plots with the Ministry, submit seed certificates, and accept random THC sampling. Serbia is a regional hemp producer with several thousand hectares dedicated to seed and fiber. The Provincial Secretariat for Agriculture in Vojvodina supports research and limited extraction trials, but flower-derived cannabinoid production triggers ALIMS pharmaceutical oversight.

Crops testing above 0.3% THC must be destroyed and the grower may forfeit eligibility for future permits. Operating without a permit is a misdemeanor under the Law on Plant Health and may escalate to narcotic offenses under the Criminal Code.

This page is for informational purposes only and does not constitute legal advice. Verify current law with qualified counsel before making compliance decisions.

Key facts ·

Serbia

Key facts

Rules at a glance

All countries

THC limit

0.3% delta-9 THC field threshold

Regulator

Ministry of Agriculture, Forestry and Water Management; Plant Protection Administration

Key regulation

Law on Plant Health; Rulebook on Hemp Cultivation

Effective

January 1, 2022

Adult-use cannabis

Illegal

Medical cannabis

Illegal

For brands and importers

Import and export rules

Hemp seed and fiber exports require permits from the Plant Protection Administration. Imports of viable seed need phytosanitary certificates. As a non-EU country, Serbia faces customs duties under EU trade agreements, and hemp flower exports for extraction face strict destination-country narcotic rules.

FAQ

Common questions

Latest

Latest news and analysis

All news
No items found.